Literature DB >> 3499399

Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up.

M Blombäck1, H Kjellman, S Schulman, N Egberg, B Böttiger, B Wiechel.   

Abstract

Immunoglobulins and aminotransferases were followed in 66 haemophilia patients and 13 von Willebrand patients over a six-year period. The results were correlated to HIV serology and lymphocyte subsets. Elevated IgG levels were found in 29/53 patients with haemophilia A, 2/13 with haemophilia B and in 0/13 with von Willebrand's disease. Elevated IgA and IgM levels were seen in 20% and 27% of the patients respectively, with a distribution similar to the elevated IgG levels, except that elevated IgA and IgM levels were also seen in 4/13 patients with von Willebrand's disease. Patients with HIV antibodies had significantly higher immunoglobulin levels than seronegative patients, and this elevation occurred in connection with seroconversion in the majority of the former. The IgG levels could not be correlated to the T4 cell count, but there has been a trend to less clinical symptoms related to HIV infection among those with stable IgG levels during the past few years. No correlation was found between elevated IgG levels and the aminotransferase levels, nor was any correlation found with the amount of blood coagulation factor concentrate given to the patients. The elevation of immunoglobulins observed in our haemophiliacs is multifactorial, but HIV infection is maybe the most important mechanism. The longitudinal IgG pattern may contribute to the prediction of the clinical outcome of this infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499399     DOI: 10.1007/BF01644125

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  25 in total

1.  Inhibition of human T lymphocyte proliferation in vitro by commercial factor VIII concentrates.

Authors:  Y Wang; E A Beck; M Furlan; A L de Weck
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

2.  A diffusable factor in Scottish coagulation factor concentrates can inhibit lymphocyte transformation in vitro.

Authors:  C McDonald; V Jackson; D C Kilpatrick; P L Yap; C Prowse
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

3.  Normal T-cell subset ratios in patients with severe haemophilia A treated with cryoprecipitate.

Authors:  V P Rasi; J L Koistinen; C M Lohman; O J Silvennoinen
Journal:  Lancet       Date:  1984-02-25       Impact factor: 79.321

4.  An automated turbidimetric immunoassay for plasma proteins.

Authors:  K Bergström; A K Lefvert
Journal:  Scand J Clin Lab Invest       Date:  1980       Impact factor: 1.713

5.  Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.

Authors:  C A Ludlam; J Tucker; C M Steel; R S Tedder; R Cheingsong-Popov; R A Weiss; D B McClelland; I Philp; R J Prescott
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

6.  Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.

Authors:  R Carr; S E Veitch; E Edmond; J F Peutherer; R J Prescott; C M Steel; C A Ludlam
Journal:  Lancet       Date:  1984-06-30       Impact factor: 79.321

7.  Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus.

Authors:  C Saxinger; R C Gallo
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

8.  Transmissibility of human immunodeficiency virus in haemophilic and non-haemophilic children living in a private school in France.

Authors:  A Berthier; S Chamaret; R Fauchet; J Fonlupt; N Genetet; M Gueguen; M Pommereuil; A Ruffault; L Montagnier
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

9.  A study of cell mediated and humoral immunity in haemophilia and related disorders.

Authors:  E H Moffat; A L Bloom; J Jones; N Matthews; R G Newcombe
Journal:  Br J Haematol       Date:  1985-09       Impact factor: 6.998

10.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  2 in total

1.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

2.  HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008.

Authors:  Hans-Jürgen Stellbrink; S Baldus; G Behrens; J R Bogner; T Harrer; C Hoffmann; J van Lunzen; J Münch; P Racz; C Scheller; M Stoll; K Tenner-Racz; J Rockstroh
Journal:  Eur J Med Res       Date:  2010-01-29       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.